Log In
CQMS
Make a Donation
Log In
Donate
DONATE OR FUNDRAISE
Donate
Read Roland's story about participating in a prostate cancer trial
Catch up with the news from our 2026 Annual Scientific Meeting
First participant recruited for new lung cancer trial
Trial offers promise for new kidney cancer treatment option
Read about TROG trials in the international spotlight

TROG 96.05 – Neuropathic Bone

Completed
Symptom management

A Prospective Randomised Trial of Single Fraction Verses Fractionated Radiotherapy of Neuropathic Pain Due to Bone Metastases

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 96.06 – Melanoma (Phase II)

Next Post

TROG 96.04 – Liver Metastases – Glucocorticoid Steroids

Related Post

World Radiotherapy Awareness Day promotion at ESTRO26
10 June, 2026

Global cancer community prepares to unite for 2026 World Radiotherapy Awareness Day

LATEST NEWS: 10 June 2026 The global radiation therapy

4 June, 2026

Report showcases a year of impactful research, collaboration and consumer engagement

LATEST NEWS: 4 June 2025 TROG’s latest Annual Research